{
  "docId": "019de071-1bdd-70bb-9c61-980d0c38b663",
  "docSlug": "a4792f18c57ea3f4ba27e696a63520de",
  "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.4148858,
  "pageNumber": 4,
  "pageCount": 40,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a column-based layout to segment the portfolio by therapeutic area.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/4",
  "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663",
  "deckJsonHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663.json",
  "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.906,
        "x": 0.047,
        "y": 0.285
      },
      "kind": "framework",
      "text": "Portfolio segmentation by cancer type",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "80c9ec0b-de44-45c0-a88c-b31ae5a165ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.906,
        "x": 0.047,
        "y": 0.285
      },
      "kind": "list",
      "text": "Lung cancer, Multiple cancers, Blood cancers",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b4661ed-61fd-4f6b-b88b-73b59248c024",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.906,
        "x": 0.047,
        "y": 0.845
      },
      "kind": "source-note",
      "text": "1. Approved medicines only 2. Non-small cell lung cancer 3. Epidermal growth factor receptor mutation 4. 1st line 5. Substitution of threonine (T) with methionine (M) at position 790 of exon 20 mutation 6. 2nd line 7. Small cell lung cancer 8. Exact patient population varies by indication 9. 3rd line 10. Human epidermal growth factor receptor 2 positive.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea7d5266-52fb-4e4c-bce8-927ccd82ffd1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.906,
        "x": 0.047,
        "y": 0.755
      },
      "kind": "title",
      "text": "What's next: a rich early to mid-stage pipeline, including combinations and several new Phase III medicines",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2cddb7db-f057-4316-8c2e-e8b522fc5044",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.645,
        "x": 0.047,
        "y": 0.145
      },
      "kind": "title",
      "text": "Oncology: a leading, diversified portfolio",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d414748-65cb-4128-af7b-8efc1e95ad08",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "c1f10eb2-caaf-4bfb-98a3-e1dd0cae5830",
      "evidence": "Portfolio segmentation by cancer type",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "market-segmentation-pyramid",
      "slug": null,
      "matchId": "fcccc723-3c19-462c-b677-dfae6c1c7673",
      "evidence": "The slide segments the oncology portfolio by cancer type (Lung, Multiple, Blood) and further by indication and future pipeline.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 4,
      "beatId": "7159cdd6-69bd-490b-9adf-e3d02ec358ec",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The document highlights the need for innovation in oncology and AstraZeneca's position in the market.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 4,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "cb0be392-a7b1-4037-8b53-e6e6f869695a",
      "evidence": "The document highlights several trends and patterns in oncology, including the importance of combinations and new Phase III medicines.",
      "position": 0,
      "objective": "What are the key trends and patterns in oncology?",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.6,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}